Quick search:
Content Search
Result Content Research
Result Content Research
1 Altamira Therapeutics : Corporate Presentation September 2021
2 Encision signs supply agreement with J&J's Auris Health
3 Auris Medical Announces Launch of New Corporate Website
4 After flops and setbacks, Auris Medical pivots to RNA with Trasir Therapeutics buyout
5 Global Tinnitus Drug Pipeline Landscape Report 2021
6 Altamira Therapeutics : Condensed Consolidated Interim Statement of Profit or Loss and Other Comprehensive Income or Loss (unaudited) (Form 6-K)
7 Auris Medical to Provide Business Update on AM-301 Program
8 Encision Signs Supply Agreement with Auris Health, Inc.
9 C auris Transmission Can be Contained in Postacute Care Settings
10 Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2
11 Medical Robots Market Size, Growth, and Key Players – Intuitive Surgical, Hocoma, Stryker Corporation, Mazor Robotics, Hansen Medical (A Wholly Owned Subsidiary of Auris Surgical Robotics), Accuray, Omnicell – Stillwater Current
12 Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India
13 Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market
14 Drugs in Development Might Help Fight Deadly Candida Auris
15 Auris Medical to Develop KRAS-Targeting RNA Treatment for
16 Auris Medical Provides Update on Bentrio Program in Allergy
17 'It can be done': Public health officials contain C . auris in California facilities
18 Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results
19 Preventing a Candida Auris Outbreak in the Health Care Setting
20 Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine
21 Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial
22 Auris Medical Holding to Present at LD Micro Invitational XI Conference
23 Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis
24 Auris Medical Holding Ltd. Prices $8,000,000 Common Shares
25 Auris Medical Announces Completion of Bentrio Conformity
26 Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany
27 Rapid intervention can contain multidrug-resistant Candida auris
28 Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
29 Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV
30 Encision shares up on deal with J&J unit
31 EARS Stock: 7 Things for Auris Medical Investors to Know as Shares Continue to Soar
32 Where Will Auris Medical Holding Ltd (EARS) Stock Go Next After It Is Down 0.00% in a Week?
33 Auris Medical Pivots to RNA Therapeutics With Focus on KRAS-Driven Colorectal Cancer
34 Ominous combination: COVID‐19 disease and Candida auris fungemia—Case report and review of the literature
35 Auris Medical (EARS) Stock in Focus Ahead of Key Business Update – Own Snap
36 Are Insiders Buying Auris Medical Holding Ltd. (NASDAQ:EARS) Stock?
37 Auris Medical Holding Ltd (EARS) Stock Decreases -18.54% This Week; Should You Buy?
38 EARS Stock: Over 9% Increase Pre-Market Explanation
39 Altamira Therapeutics : to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
40 Why Auris Medical's Stock Is Trading Higher By 445% Today
41 Boosted Surveillance, Infection Control Swiftly Contained ’Super Bug’
42 Insights into Infection Control in a New York City-Based Hospital System
43 EARS Stock Price Increased 52.05%: Why It Happened
44 COVID-19 may promote the spread of drug-resistant Candida auris
45 Auris Medical Holding Ltd (EARS) gains 2.7100% for June 03
46 OVID Plunges, VNDA's Hetlioz Scores Another FDA Nod, Auris Investors Smile Ear To Ear
47 Johnson & Johnson-owned Peninsula medical robotics company Auris Health has signed a lease for 76,000 square feet in San Jose
48 J&J's Gorsky to step down as CEO
49 Students Present Their Summer Research Projects
50 Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal
51 Global Medical Robots Market Worldwide Robust Expansion||Covid-19 impact Analysis By CMR Surgical Ltd, Auris Health Inc., Accuray Incorporated, Omnicell Inc., ARxIUM, Ekso Bionics, Capsa Healthcare – The Manomet Current
52 Auris Medical Announces Reverse Stock Split
53 Robotic Surgery Consumables Market 2021 Global Demand and Emerging Trends by 2028- Intuitive Surgical,Stryker,Medtronic,Stereotaxis – Stillwater Current
54 Rare, often deadly Candida auris fungal infection identified in Oakland County man
55 Antimicrobial Resistance Is Futile Without IPs' Help
56 Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
57 Auris Medical Provides Update on Intranasal Betahistine
58 'Superbug' Candida Auris Fungus Spreads in US
59 BRIEF-Auris Medical Provides Update On Ongoing Clinical Trials With Intranasal Betahistine
60 Auris Medical's Acute Inner Ear Hearing Loss Candidate Fails Phase III Trial
61 Auris Medical gives up on AM-111 trial in sudden deafness
62 Candida Auris: What to Know
63 As Covid Cases Rise, So Do Hospital-Related Infections
64 Zimmermann replaces ex-Roche pRED chief as Inotrem CEO
65 Auris Health Announces Publication of Results from BENEFIT Study of MONARCH® Platform in CHEST
66 CDI Director Perlin Named to Modern Healthcare's Class of Top 25 Innovators
67 Auris Medical off-target on tinnitus drug study
68 Traders boost the wrong stock for a second time after J&J takeover
69 Auris Medical stock slumps 54% premarket as company says tinnitus trial missed goals
70 Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019
71 Intranasal Approaches Have Potential As Vaccines & Therapies for COVID-19
72 Stocks That Hit 52-Week Highs On Tuesday
73 The History of Robotic-Assisted Surgery
74 Team that sold Auris Health to Johnson & Johnson for nearly $6 billion raises $300 million in 'blank check' IPO
75 Global Tinnitus Pipeline Insight Report 2021: Focus on Key Players, Major Products and Research Programmes
76 Sorrento Therapeutics developing antibodies injection and nose drops to fight Covid-19
77 Auris Medical's Tinnitus Candidate Keyzilen Fails Second Phase III Trial
78 Public Health Watch: CDC Warns of First Case “Clusters” of “Pan-Resistant” Candida Auris in US
79 Virginia medical facilities grapple with a new worry — a rise in drug-resistant fungus infections
80 'Landmark discovery': C. auris isolated from environment for first time
81 Candida auris: Symptoms, spread, and outbreak risk
82 J&J touts results of robotic bronchoscopy trial
83 Study: Multidrug-resistant fungus that infests hospitals may have emerged from the wild
84 Drug-Resistant Fungal 'Superbug' Has Appeared
85 EMA gives go-ahead to new Auris trial for hearing loss drug
86 Epidemiological Alert: Candida auris outbreaks in health care services in the context of the COVID-19 pandemic, 6 February 2021
87 Surgical Robotics and Navigation Market will Witness Huge Growth till 2027 & Covid-19 Analysis | Titan Medical
88 Auris Medical Provides Update on Tinnitus Drug Development Strategy
89 56 Stocks Moving In Friday's Mid-Day Session
90 Tinnitus Market is expected to offer immense opportunity to pharmaceutical and medical device companies
91 GME, BNGO, XSPA and WPG among premarket gainers
92 82 Biggest Movers From Yesterday
93 Deadly fungus behind global hospital outbreaks traced to tropical island 'Medical mystery'
94 BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system
95 Collin County Says Candida Auris Fungus Responsible For 4 Deaths
96 Johnson & Johnson's new robotic surgical system to rival Intuitive Surgical's da Vinci
97 5 Reddit Penny Stocks to Watch That Are Moving Right Now
98 42 Stocks Moving In Monday's Mid-Day Session
99 FDA clears J&J's robotic surgery system for total knee replacements
100 With All Eyes on Covid-19, Drug-Resistant Infections Crept In